Phase I, open-label, parallel-group volunteer study to assess the pharmacokinetics and safety of SKY0402 in subjects with impaired hepatic function.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2011
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- 02 Mar 2011 Results reported at the 112th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in March 2011, according to a Pacira Pharmaceuticals media release.
- 16 Jun 2009 Primary outcome amended as reported by ClinicalTrials.gov
- 16 Jun 2009 Planned end date changed from 1 Apr 2009 to 1 Aug 2009 as reported by ClinicalTrials.gov